Levine LA, Newell M andTaylor FL: Penile traction therapy for treatment of Peyronie's disease: a single- center pilot study
Study 8 (TAUSSIG, NCT01624142) was a multicenter, open-label 5-year extension study with REPATHA in 106 patients with HoFH, who were treated with REPATHA as an adjunct to other lipid-lowering therapies
The White House did not immediately respond to an inquiry about potential plans to put the president on weight-loss medication, which he has previously dubbed fat drugs. Trump made the admission just days after he asked photographers to make him look thin. Trump was delivering remarks at a GOP retreat at the Kennedy Center on Tuesday when he noticed Doug Mills, a photographer for the Times, in front of him
Most patients experience improvement as their bodies adjust to the medication over 48 weeks, though some individuals may have persistent symptoms requiring intervention
Neuroimaging and behavioral research suggest involvement of limbic structures linked to reward anticipation
